ELAVL2 gene – Talk Bio

Biogen’s New Global Headquarters: Consolidating Operations in Cambridge

3 months ago talkbio0Tagged Biogen, Cambridge, ELAVL2 gene, headquarters, innovation, Kendall Square, Open

Biogen, Cambridge, Kendall Square, headquarters consolidation, innovation hub, 2028 opening

GE HealthCare and UCSF Collaborate on Innovative Imaging Solutions for Cancer and Neurodegenerative Diseases

5 months ago talkbio0Tagged brain health, Cancer Imaging, ELAVL2 gene, GE HealthCare, innovation, Joint Research Program, Neoplasms, Neurodegenerative Disease Imaging, Precision - temporal, UCSF

GE HealthCare, UCSF, Cancer Imaging, Neurodegenerative Disease Imaging, Precision Oncology, Brain Health, Joint Research Program, Care Innovation Hub

GE HealthCare and UCSF Launch ‘Care Innovation Hub’ to Revolutionize Medical Imaging for Cancer and Neurodegenerative Diseases

5 months ago talkbio0Tagged Automated (qualifier value), brain health, ELAVL2 gene, GE HealthCare, innovation, Magnetic Resonance Imaging, Medical Imaging, Neoplasms, Neurodegenerative Disorders, Precision - temporal, radiopharmaceutical therapies, UCSF

GE HealthCare, UCSF, Care Innovation Hub, medical imaging, cancer, neurodegenerative diseases, precision oncology, brain health, automated imaging techniques, MRI, radiopharmaceutical therapies.

Bayer Announces 150 Job Cuts in Basel, Switzerland, Amid Global Restructuring

10 months ago talkbio0Tagged basel, Bayer, Consumer, ELAVL2 gene, restructuring, Switzerland

Bayer layoffs, Basel, Switzerland, consumer health hub, job cuts, restructuring

Eli Lilly Unveils State-of-the-Art Genetic Medicine Research Center in Boston

10 months ago talkbio0Tagged City of Boston, ELAVL2 gene, Eli, Eli Lilly, genetic medicines, innovation

Eli Lilly, Boston, genetic medicines, research center, innovation hub, biotech